Phi Wiegn

Title: Phi Wiegn: Innovator in Vascular Research

Introduction

Phi Wiegn is a notable inventor based in New York, NY (US), recognized for his contributions to the field of vascular research. He holds 2 patents that focus on innovative methods for enhancing vascular density and promoting the viability of endothelial cells.

Latest Patents

His latest patents include "Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands." This invention relates to methods of inducing or inhibiting the angiogenic process and promoting vessel growth or stabilization in an organ by modulating the trk receptor pathway. It also encompasses a method for treating pathological disorders by administering a trk receptor ligand or an inhibitor of its expression or activity. Additionally, it provides a method for screening modulators of angiogenesis and diagnosing or monitoring pathological disorders through the presence or amount of a trk receptor ligand in biological samples. Another patent is titled "Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands," which shares similar objectives and methodologies.

Career Highlights

Throughout his career, Phi Wiegn has worked with esteemed institutions such as Cornell University and Children's Medical Center Corporation. His work has significantly advanced the understanding of vascular biology and therapeutic approaches to related disorders.

Collaborations

Phi has collaborated with notable colleagues, including Barbara L. Hempstead and Shahin Rafii, contributing to a rich exchange of ideas and research in the field.

Conclusion

Phi Wiegn's innovative work in vascular research and his patents demonstrate his commitment to advancing medical science. His contributions have the potential to impact the treatment of various pathological conditions significantly.